|Videos|November 14, 2019
AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium
Author(s)AMCP Nexus 2019 Street Team
Advertisement
At AMCP 2019, Cate Lockhart, MS, PharmD, PhD, executive director at Biologics and Biosimilars Collective Intelligence Consortium, discusses accelerating the uptake of biosimilars in the U.S. market.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Review calls for combining outcome measures for hidradenitis suppurativa treatment
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Transparency is out. Actionable data is in. | PBMI 2026
4
States push for new PBM reporting rules | PBMI 2026
5












